Introduction
============

Self-renewal of adult stem cells is generally supported by a specialized niche microenvironment, which can serve to maintain stem cells in an appropriate location, in an undifferentiated state or in an appropriate proliferative state. For example, a short-range bone morphogenetic protein (BMP) signal produced in directly adjacent cap cells ([Fig. 1 A](#fig1){ref-type="fig"}) promotes germline stem cell (GSC) maintenance in the *Drosophila melanogaster* ovary by repressing a key differentiation factor ([@bib5]). BMP similarly represses differentiation in the male GSC lineage, whereas a Janus kinase--signal transducer and activator of transcription (JAK-STAT) pathway ligand produced in directly adjacent hub cells represses differentiation of somatic stem cells in the *Drosophila* testis ([@bib25]; [@bib27]). These and other findings firmly established repression of differentiation as a, likely widespread, mechanism for niche signals to maintain stem cells ([@bib25]). Other potential mechanisms for niche signals to support stem cells have not been fully explored and validated.

![**Yki is required for FSC maintenance.** (A) *Drosophila* germarium: germline stem cells (GSC) produce cystoblast (CB) daughters, which proliferate to form 16-cell cysts (black) while surrounded by somatic escort cells (ECs). Follicle stem cells (FSC) just anterior (left) to region 2b cysts, which span the germarium, produce follicle cells (FC), which express Fas3 (red) at their surface and envelop germline cysts. A typical single FSC clone lineage is indicated by green nuclei. Hh is expressed strongly in anterior terminal filament (TF) and cap cells (CC), whereas the JAK-STAT pathway ligand is expressed strongly in polar FCs at the posterior of the germarium. (B) Percentage of ovarioles that contain wild-type (WT) or *yki^B5^* FSC or GSC clones 9--18 d after clone induction in 2-d-old adults. (C) The percentage of ovarioles that maintain *yki^B5^* FSC clones 12 d after induction in larvae was greatly increased by coexpression of both *UAS-diap1* and *UAS-cycE* transgenes. Error bars in B and C show SDs; *n* = 3, with ≥100 ovarioles scored in each measurement. (D--G′) D and E show clones marked by the loss of GFP, whereas F and G show MARCM clones marked by expression of GFP. In all cases, clones were induced 12 d earlier, ovarioles were stained with Fas3, and close-ups of the FSC region are shown (D′, E′, F′, and G′). Red bars, 10 µm. (D) The wild-type FSC clone includes an FSC (arrowhead) just anterior (left) to Fas3 staining and many FC derivatives (white lines). (E) In most *yki^B5^* ovarioles, all FSCs (arrowhead) and FCs express GFP, indicating the absence of *yki* mutant FSCs, but GFP-negative germline cysts (asterisks) and GSCs were frequently present, indicating continued activity of *yki* mutant GSCs. (F) *yki* mutant FSCs expressing transgenic DIAP1 were generally not maintained for 12 d, but some ovarioles include a patch of GFP-marked FCs (white line), indicating that the marked FSC (arrowhead) was lost within the last 5 d. (G) Excess DIAP1 and CycE together rescued the maintenance of *yki* mutant FSCs in many ovarioles to produce clones with a marked FSC (arrowhead) and FC derivatives (white lines).](JCB_201309141_Fig1){#fig1}

Although stem cells must proliferate to serve their regenerative function, relative quiescence was once thought to be universally important for long-term maintenance of stem cells. Several types of stem cells, including mammalian hematopoietic stem cells (HSCs) and muscle stem cells, indeed divide infrequently, whereas normal cycles of hair growth depend on maintaining quiescence of hair follicle stem cells (FSCs) in between brief periods of activation ([@bib34]; [@bib4]; [@bib12]). However, it is now clear that some adult stem cells, including mammalian epidermal and gut stem cells proliferate constitutively and extensively ([@bib42]; [@bib12]). In all of these cases, there are likely specific niche signals, some of which have been identified, that stimulate or inhibit stem cell proliferation to produce an appropriate supply of tissue-replenishing daughters. However, an important question that has been hard to resolve is whether regulation of the rate of stem cell proliferation by niche factors is also a major mechanism for regulating the maintenance of the stem cells themselves.

*Drosophila* FSCs provide a particularly informative stem cell paradigm for understanding niche function because FSC maintenance depends on multiple known extracellular signals and FSCs compete for niche occupation ([@bib30], [@bib31]; [@bib48]). FSCs are maintained midway along the anterior--posterior (AP) axis of the germarium, at the region 2a/2b border; here, rounded stage 2a germline cysts shorten along the AP axis to form lens-shaped stage 2b cysts that span the width of the germarium for the first time ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib26]). FSCs self-renew and produce follicle cell (FC) daughters, which proliferate as they form a monolayer epithelium around passing germline cysts and also become specialized stalk cells that separate egg chambers as they bud from the posterior of the germarium ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib30], [@bib31]; [@bib52]). FSC maintenance depends on Wnt and BMP niche signals, but the Hedgehog (Hh) and JAK-STAT pathways are the most potent regulators of FSC maintenance and expansion ([@bib43]; [@bib18]; [@bib48]). Hh and the JAK-STAT pathway ligand, Unpaired, derive from opposite ends of the germarium, producing reciprocal AP gradients that overlap in region 2a/b to induce sufficiently high activity in each pathway to support FSCs ([@bib48]). How those signals act within FSCs to promote their maintenance or duplication has not yet been determined.

FSCs are constitutively active in well-fed flies, supporting the production of up to two egg chambers per day from each germarium ([@bib26]), and are therefore a good model for highly proliferative mammalian stem cells. We had previously suggested that FSC proliferation promotes FSC maintenance based on artificial genetic conditions: several homozygous mutations expected to decrease cell proliferation, including partial loss of function *cyclin E* (*cycE*) mutations, caused cell-autonomous loss of FSCs, whereas excess CycE compensated for the loss of several otherwise essential FSC factors ([@bib49]; [@bib50]). We therefore sought to understand how proliferation is regulated in FSCs and whether regulation of the rate of FSC proliferation by niche signals affects stem cell maintenance or stem cell numbers. Here, we show that Hh signaling induces the Hippo (Hpo) pathway coactivator Yorkie (Yki) in FSCs and that Yki, in turn, regulates FSC maintenance and expansion by stimulating FSC proliferation via induction of CycE and by preventing apoptosis. These causal connections provide clear evidence that a niche signal can regulate stem cell maintenance by controlling the rate of stem cell proliferation.

Results
=======

Yki is required for FSC maintenance
-----------------------------------

The Hpo pathway has recently emerged as a major regulator of organ size and of the growth, cycling, and survival of individual cells in *Drosophila* and mammals, motivating exploration of its potential roles governing stem cell proliferation ([@bib33]; [@bib55]; [@bib36]). To investigate Hpo pathway function in FSCs, we induced marked homozygous mutant FSCs at a fixed time by using a heat shock--inducible *flp* recombinase and *FRT* recombination targets located at the base of the appropriate chromosome arm. We then scored the percentage of ovarioles that retained marked (GFP negative) FSC and FC descendants (an FSC clone; [Fig. 1, A and D](#fig1){ref-type="fig"}) over time. The earliest time interval used in this well-established assay is generally 7 d ([@bib47]; [@bib49]; [@bib48]; [@bib50]) to ensure that "all-marked" cells originated from an FSC. Derivatives of *FRT*-mediated recombination in FCs (transient FC clones) normally pass through the ovariole in 5 d or less ([@bib26]). FSC clones lacking activity of Yki, the key regulated transcriptional coactivator of the Hpo pathway, were lost very rapidly relative to controls when clones were induced in adults or in larvae (shortly before FSC establishment; [Fig. 1, B--E](#fig1){ref-type="fig"}; [@bib48]).

We examined earlier time points by focusing only on the germarium, which should not retain transient FC clones beyond 3 d. At 4 d after clone induction, *yki* mutant FSCs were present in 13% of germaria compared with 71% for controls. Moreover, only 5% of germaria contained marked wild-type FCs but no FSC, whereas 30% of germaria contained *yki* mutant FCs but no FSC, directly revealing accelerated *yki* mutant FSC loss ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp1}).

In contrast, *yki* mutant GSCs, which also reside in the germarium and can be assayed in parallel by exactly analogous methodology, were maintained normally over 18 d ([Fig. 1, B and E](#fig1){ref-type="fig"}). A selective requirement in FSCs but not GSCs has been observed previously for several other regulators of FSC behavior ([@bib50]).

Most FSC daughters divide about eight times over a 3--4-d period before differentiating as mature FCs and dying 2--3 d later ([@bib26]). The proliferation of these FCs is not impaired by partial loss-of-function *cycE* mutations or by several other mutations in FSC-selective factors that drastically reduce FSC persistence ([@bib49]; [@bib50]). However, *yki* mutant clones (marked by loss of GFP) induced in FCs and captured five or fewer days after induction were much smaller than the "twin spot" wild-type clones (marked by two copies of the *ubiquitin* \[*ubi*\]*-GFP* gene), which are generated simultaneously ([Fig. 2, A--C](#fig2){ref-type="fig"}). Yki commonly regulates both cell cycling and apoptosis. Apoptosis was detected in *yki* mutant FCs by activated Capase-3 staining in \>15% of *yki* mutant FSC clones 4 d after induction compared with \<2% of control FSC clones (Fig. S1, B--D). We also found that expression of a *DIAP1* transgene, which inhibits apoptosis, in (GFP positive) *yki* mutant FC clones made by the mosaic analysis with a repressible cell marker (MARCM) method ([@bib21]), restored their size to normal; in contrast, expressing excess CycE did not alter *yki* mutant FC clone size ([Fig. 2, D--H](#fig2){ref-type="fig"}). Thus, net expansion of *yki* mutant FC clones is limited principally by cell death.

![**Yki is important for net FC amplification principally by preventing apoptosis.** (A and B) Stage 10 egg chambers with control (wild type \[WT\]) or *yki* mutant clones lacking GFP (green, outlined in yellow) and adjacent wild-type twin spot clones with two copies of the GFP transgene (brighter green, outlined in white). Control clones were of similar size to simultaneously generated twin spots (A), but *yki* mutant clones were much smaller (B). (C) Mean number of cells in a GFP-negative clone divided by the number of cells in a twin spot, calculated for 20 (wild type) or 25 (*yki*) clones. Error bars show SDs. (D--G) Clones derived from single FCs formed patches (green nuclei, outlined in yellow) in stage 10 egg chambers that were much smaller than wild type (D) for *yki* mutant FCs (E); normal clone size was restored by expressing excess DIAP1 (G), but not CycE (F), in the clone. (H) Mean number of cells in a clone for wild-type and *yki* FCs expressing the indicated transgenes in the clone. Error bars show SDs, and number of clones measured is indicated in parentheses. Red bars, 15 µm.](JCB_201309141_Fig2){#fig2}

Coexpression of DIAP1 in MARCM clones did not, however, prevent the rapid loss of *yki* mutant FSCs ([Fig. 1, C and F](#fig1){ref-type="fig"}). Excess CycE was similarly ineffective. However, excess CycE and DIAP1 together substantially rescued *yki* FSC maintenance ([Fig. 1, C and G](#fig1){ref-type="fig"}). Hence, *yki* has an important antiapoptotic function throughout the FSC lineage, but it also has a selective function in FSCs connected with stimulating cell cycling that is not critical for FCs or indeed for GSCs.

FSCs with increased Yki activity compete better
-----------------------------------------------

In *Drosophila* and mammals, upstream components of the Hpo pathway regulate the specific activity of Yki proteins. A major mechanism involves regulation of the nuclear entry and activity of Yki orthologues by phosphorylation at conserved sites, including S168 in *Drosophila* Yki ([@bib33]; [@bib44]). The protein kinase directly responsible, Warts (Wts), is itself phosphorylated and activated by the Hpo protein kinase in a complex with the scaffolding protein Salvador (Sav). Hence, loss of *hpo*, *sav*, or *wts* generally activates Yki protein. We found that *hpo*, *wts*, and *sav* mutant FSC clones produced striking overrepresentation phenotypes, indicating enhanced FSC activity ([Fig. 3, A and C](#fig3){ref-type="fig"}; and [Fig. S2 B](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp2}). Each germarium contains more than one FSC. Consequently, marked wild-type FSC clones are almost always accompanied by unmarked FSC derivatives in mosaic ovarioles ([Fig. 1, A and D](#fig1){ref-type="fig"}). However, a significant proportion of *hpo*, *wts*, and *sav* mutant FSC clones occupied the entire ovariole (all-marked clones; [Fig. 3, A and C](#fig3){ref-type="fig"}; and Fig. S2 B), as seen previously for genetic changes (*patched* \[*ptc*\] mutation) that increase Hh ([Fig. 3 D](#fig3){ref-type="fig"}), JAK-STAT, or phosphatidyl inositol 3′-kinase pathway activities ([@bib48]; [@bib50]). Production of an all-marked clone from a single FSC implies that the marked FSC duplicated and out-competed unmarked FSCs in the same germarium ([@bib30]; [@bib48]). The frequency of all-marked clones continued to increase over time (36% for *hpo* with 28% mosaic and 39% for *ptc* with 34% mosaic at 26 d after clone induction in adults), as might be expected for FSCs with a stable competitive advantage. *hpo*, *wts*, and *sav* mutant FSC clones were also maintained better than wild-type FSC clones ([Fig. 3 A](#fig3){ref-type="fig"}). The frequency of all-marked ovarioles for *hpo*, *wts*, and *sav* was significantly higher for FSC clones induced in larvae rather than in adults ([Fig. 3 A](#fig3){ref-type="fig"}), as observed previously for excess Hh, phosphatidyl inositol 3′-kinase, or JAK-STAT pathway activity, consistent with the idea that competition among potential stem cells is particularly intense during FSC establishment ([@bib48]; [@bib50]).

![**FSCs with increased Yki activity displace wild-type FSCs and produce FC hypertrophy.** (A and B) Percentage of ovarioles containing marked FSC clones 12 d after induction in larvae or adults. Dark red and blue columns show the percentage of all-marked (A.M.) ovarioles, containing only marked FSCs and FCs. To the left of each group of mutant genotypes is the control (wild type \[WT\]) for the appropriate chromosome arm (2R, 3R, X, or 2L) that becomes homozygous in clones. Error bars show SDs; *n* = 3, with ≥100 ovarioles scored in each measurement. Values for adult FSC clones are from one experiment. Significant differences from WT all-marked values for all-marked FSC clones using Fisher's exact two-tailed test with P \< 0.05 are indicated by asterisks. (C--D′) All-marked ovarioles (C and D) and enlarged germarial regions (C′ and D′), stained for Fas3, contained only GFP-negative FSCs (arrowheads) and FCs, which are homozygous for the indicated mutations, and included multilayering of FCs (yellow lines) and accumulation of FCs between egg chambers (white lines). Red bars, 10 µm.](JCB_201309141_Fig3){#fig3}

The all-marked *hpo*, *wts*, and *sav* FSC clones also produced an excessive number of FCs, which accumulated between egg chambers or formed multilayered epithelia ([Fig. 3 C](#fig3){ref-type="fig"} and Fig. S2 B). Those phenotypes are reminiscent of *ptc* mutant FSC clones ([Fig. 3 D](#fig3){ref-type="fig"}), which have elevated Hh pathway activity, and differ from the phenotypes produced by FSCs with increased phosphatidyl inositol 3′-kinase or JAK-STAT pathway activity ([@bib48]; [@bib50]).

FSC clones lacking both Hpo and Yki activity were lost just as rapidly as *yki* mutant FSCs ([Fig. 3 A](#fig3){ref-type="fig"}), consistent with the expectation that *hpo* mutant phenotypes are induced entirely by excessive activation of Yki. Indeed, phenotypes analogous to those of *hpo*, *wts*, and *sav* were produced by expression of Yki with an activating S168A alteration in GFP-positive MARCM FSC clones ([Fig. 4 D](#fig4){ref-type="fig"} and Fig. S2, F and G). Thus, FSCs with elevated Yki activity outcompete wild-type FSCs for retention in the germarium and become overrepresented.

![**Regulation of FSC proliferation by the Hpo pathway is critical for FSC maintenance.** (A) Percentage of marked FSCs and FCs of indicated genotypes labeled by EdU during a 1-h incubation 6 d after clone induction. Significant differences from control (wild type \[WT\]) values by Fisher's exact two-tailed test are indicated for P \< 0.05 by the asterisks. For *yki* and *smo* FSCs (marked by \#), P \< 0.05 after adding the data shown in [Fig. S5 B](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp3}. Key comparisons are highlighted by red brackets. (B and C) Examples of EdU labeling of germaria containing positively marked FSC clones (green) and stained for Fas3, showing positions of FSCs, FCs, region 1 and 2a ECs (1 EC and 2a EC), and cells in the same dorsoventral plane as FSCs (2a/2b cells), all of which were scored separately ([Table S1](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp4}). (D) Percentage of ovarioles with marked FSC clones of indicated genotypes 12 d after induction in larvae (dark red indicates all-marked clones). For all genotypes with *cycE* mutations, both hypomorphic (*cycE^WX^*, left, solid shading) and null (*cycE^AR95^*, right, angled stripes) alleles were tested. Error bars show SDs; *n* = 3, with ≥100 ovarioles scored in each measurement. Significant differences from wild type for all-marked FSC clones using Fisher's exact two-tailed test with P \< 0.05 are indicated by asterisks. Key comparisons are highlighted by blue brackets. (E and F) Ovarioles with clones induced 12 d earlier and marked by the presence of GFP, shown together with Fas3 to reveal FSC location (arrowheads). The all-marked FSC clone phenotype and FC multilayering (yellow line) produced by loss of *ex* (E) was not observed when *UAS-cycE* complements a *cycE* mutation (F). Red bars, 10 µm.](JCB_201309141R_Fig4){#fig4}

Merlin (Mer), Expanded (Ex), and Kibra are key upstream regulators of the Hpo pathway in FSCs
---------------------------------------------------------------------------------------------

Kibra can associate with the cortical FERM (4.1 protein, Ezrin, Radixin, and Moesin) domain proteins Ex and Mer to connect external stimuli to activation of core Hpo pathway components ([@bib2]; [@bib44]). Both *ex* and *mer* mutant FSC clones survived better than wild-type clones and produced a significant frequency of all-marked ovarioles ([Fig. 3, A and B](#fig3){ref-type="fig"}). Those phenotypes were weaker than for *hpo*, *sav*, or *wts* FSC clones, whereas *kibra* mutant phenotypes were the strongest of all ([Fig. 3, A and B](#fig3){ref-type="fig"}; and Fig. S2, C--E). Thus, Kibra, Ex, and the NF2 tumor suppressor orthologue Mer are key transducers of Hpo signaling in FSCs. The transmembrane proteins, Crumbs, Echinoid, and Fat are potential upstream regulators of the Hpo pathway that limit Yki activity, but their involvement in different *Drosophila* epithelial tissues is varied ([@bib2]; [@bib44]). Mutations affecting these three proteins each failed to produce elevated frequencies of all-marked ovarioles ([Fig. 3 B](#fig3){ref-type="fig"} and Fig. S2 A), suggesting that they might act redundantly or that different, currently unknown, transmembrane sensors regulate the Hpo pathway in FSCs. Scalloped likely collaborates with Yki in the nucleus of FSCs as in several other cell types because *scalloped* mutant FSCs were lost significantly faster than control FSCs ([Fig. 3 B](#fig3){ref-type="fig"}).

Hpo--Yki pathway regulates FSCs by altering the rate of FSC proliferation
-------------------------------------------------------------------------

We then wished to test whether the Hpo pathway regulates FSC maintenance and FSC expansion by influencing cell proliferation, as suggested by our earlier finding that excess CycE together with DIAP1 substantially restored *yki* FSC maintenance ([Fig. 1, C and G](#fig1){ref-type="fig"}). To examine whether the Hpo pathway regulates proliferation in the FSC lineage, we labeled GFP-positive MARCM FSC clones of various genotypes with 5-ethynyl-2′-deoxyuridine (EdU) for 1 h in vitro and measured the EdU-labeling DNA replication index. A typical wild-type FSC clone necessarily contains a marked FSC (scored as situated adjacent to the germarial wall immediately anterior to Fasciclin3 \[Fas3\] staining), together with marked Fas3-positive FCs, which we scored in regions 2b and 3 of the germarium ([Fig. 1 A](#fig1){ref-type="fig"} and [Fig. 4, B and C](#fig4){ref-type="fig"}). We also scored marked Fas3-negative cells close to the FSC (region 2a/b cells) and marked escort cells (ECs), which occupy regions 1 and 2a of the germarium and are normally quiescent ([Fig. 4, B and C](#fig4){ref-type="fig"}; and [Table S1](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp5}; [@bib19]). The EdU labeling index, measured 6 d after clone induction, was greatly reduced for *yki* mutant FSCs (to ∼30% of wild type) and increased almost twofold for *hpo* mutant FSCs and FCs ([Fig. 4 A](#fig4){ref-type="fig"} and Table S1). Region 1 ECs were quiescent in all cases (Table S1). Thus, Yki activity is a major regulator of the rate of FSC proliferation.

We then tested whether the regulation of FSC maintenance and competition by the Hpo pathway depends on CycE, which is commonly induced by Yki to stimulate cell cycling ([@bib33]). Here, we used *ex* mutations to alter Hpo pathway activity because *ex* and *cycE* are on the same chromosome arm, facilitating testing of double mutants. These tests used both a null allele of *cycE* (*cycE^AR95^*) and an allele (*cycE*^WX^) that retains enough activity to support FC proliferation ([@bib50]). Although *ex* mutant FSCs induced in larvae normally survive better than control FSC clones and produce an elevated frequency of all-marked clones ([Fig. 4, D and E](#fig4){ref-type="fig"}), *cycE ex* double mutant FSCs were instead lost prematurely ([Fig. 4 D](#fig4){ref-type="fig"}). Similarly, expression of an activated form of Yki (*UAS-Yki^S168A^*) alone produced a strong all-marked FSC clone phenotype but failed even to rescue FSC maintenance in *cycE* mutant FSCs ([Fig. 4 D](#fig4){ref-type="fig"}). FSC maintenance can be rescued for both *cycE* alleles by constitutive expression of *UAS~GAL4~-cycE* (driven by constitutive GAL4 transgenes *tubulin* \[*tub*\]*-GAL4* and *actin* \[*act*\]*-GAL4*; [@bib49]), whereas expression of *UAS-cycE* in otherwise wild-type FSC clones has no effect ([Fig. 4 D](#fig4){ref-type="fig"}), suggesting that *UAS-cycE* is expressed at roughly normal physiological levels in FSCs. The expression of *UAS-cycE* in *ex cycE* mutant FSCs restored normal FSC maintenance but did not produce a high frequency of all-marked FSC clones or the increased longevity characteristic of *ex* mutant FSCs ([Fig. 4, D and F](#fig4){ref-type="fig"}). Thus, the induction of FSC duplication by activated Yki to form all-marked FSC clones depends on the presence of an active Yki-inducible *cycE* gene. Moreover, EdU incorporation was no longer enhanced by loss of Ex in *cycE* mutant FSCs expressing *UAS-cycE* ([Fig. S5 A](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp6}), showing that regulation of CycE expression is also critical for activated Yki to stimulate FSC proliferation. Normal FSC maintenance also appears to depend on the induction of *cycE* and proliferation by Yki because *yki* is required for both maintenance and normal cell cycling of FSCs ([Fig. 1 B](#fig1){ref-type="fig"}, Fig. S1, and [Fig. 4 A](#fig4){ref-type="fig"}), whereas excess CycE (together with DIAP1) can rescue *yki* mutant FSC maintenance ([Fig. 1 C](#fig1){ref-type="fig"}).

The Hh pathway regulates FSC proliferation and intersects with the Hpo--Yki pathway
-----------------------------------------------------------------------------------

The similarity between *ptc* and *hpo* mutant FSC phenotypes ([Fig. 3, C and D](#fig3){ref-type="fig"}; and Fig. S2, H--J) prompted us to test whether Hh signaling also regulates FSC proliferation and how the Hh and Hpo signaling pathways intersect in FSCs. The EdU labeling index was increased almost twofold for both *ptc* mutant FSCs and germarial FCs, whereas region 1 ECs remained quiescent ([Fig. 4 A](#fig4){ref-type="fig"} and Table S1). FSC proliferation has previously been shown to be increased by excess Hh signaling ([@bib11]). Conversely, the EdU labeling index was very low in *smoothened* (*smo*) mutant FSCs and germarial FCs, which cannot respond to Hh ([Fig. 4 A](#fig4){ref-type="fig"}). Thus, FSC proliferation is highly dependent on the level of Hh pathway activity. Furthermore, double mutant *ptc yki* FSC clones showed strongly reduced EdU labeling in FSCs ([Fig. 4 A](#fig4){ref-type="fig"}). Double mutant *ptc yki* FSC clones were also lost just as rapidly as *yki* FSC clones (see [Fig. 6 A](#fig6){ref-type="fig"}), showing that the effects of excess Hh on FSC duplication, maintenance, and proliferation all depend absolutely on Yki activity.

Hh signaling induces Yki activity specifically in the FSC lineage
-----------------------------------------------------------------

To test whether Hh signaling might directly stimulate Yki activity, we examined two Yki target gene reporters, *DIAP1-lacZ* and *ex-lacZ* ([@bib17]). Both reporters were readily detected in somatic cells in the ovary but not in the germline and showed increased expression cell autonomously in *hpo* mutant clones, confirming that they do report Yki activity ([Fig. 5, A, B, F, G, and K](#fig5){ref-type="fig"}; and [Fig. S3, A, B, D, E, and G](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp7}). Interestingly, FSCs expressed significantly lower levels of both *DIAP1-lacZ* and *ex-lacZ* than more posterior FC daughters or more anterior ECs ([Fig. 5, A, F, and K](#fig5){ref-type="fig"}; and Fig. S3, A, D, and G), implying that upstream Hpo pathway components (Kibra, Ex, Mer, Sav, Wts, and Hpo) are particularly active (limiting Yki protein activity) in FSCs. Loss of *yki* activity reduced *DIAP1-lacZ* expression in FCs to a level similar to that of FSCs ([Fig. S4, A, C, and I](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp8}), supporting the inference that Yki activity is normally higher in FCs than FSCs.

Strikingly, loss of *ptc* activity markedly increased *DIAP1-lacZ* and *ex-lacZ* expression in both FSCs and FCs ([Fig. 5, A, C, F, H, and K](#fig5){ref-type="fig"}; and Fig. S3, A, C, D, F, and G), indicating that excess Hh pathway activity significantly stimulates Yki activity. The cell-autonomous activation of Yki by Hh signaling seen in the FSC lineage was not observed in wing discs, where *ex-lacZ* was instead induced in a ring around each anterior *ptc* mutant clone (Fig. S3, H--M). The nonautonomous induction of *ex-lacZ* is consistent with the recent observation that Decapentaplegic (Dpp) signaling activates Yki in wing discs ([@bib16]). Dpp is induced cell autonomously by Hh pathway activity in wing discs, but the ectopic Dpp acts principally on surrounding cells because Hh pathway activity also cell-autonomously inhibits expression of the Dpp receptor Thickveins ([@bib9]).

![**Hh signaling increases Yki activity at the transcriptional level in the FSC lineage.** (A--J′) FSC clones of the indicated genotypes, marked by loss of GFP in germaria stained for Fas3 and β-galactosidase (red) encoded by a *diap1-lacZ* reporter. *diap1-lacZ* expression was lower in wild-type (WT) FSCs (arrowhead; A) than FCs (white lines) and was increased in both FSCs (arrowheads) and FCs (arrows in F--J′) for *hpo* and *ptc* genotypes (B, C, G, and H) but not in *ptc yki; tub-yki* (D and I) or *ptc mam* (E and J) genotypes. Red bars, 10 µm. (K) Quantification of *diap1-lacZ* expression levels in FSCs and FCs of the indicated genotypes. Error bars show SDs from three measurements of the same samples, as described in the Materials and methods (*n* \> 18 for FSCs and *n* \> 300 for FCs). Dotted lines indicate values for wild-type FSCs and FCs. (L) Relative mRNA levels of *diap1*, *cycE*, *ex*, *yki*, and *ptc* (indicated on top) in ovarioles containing control (wild type, blue bars), *hpo* (red bars), or *ptc* (green bars) FSC clones induced 12 d earlier in larvae. *rp49* mRNA was used to normalize total mRNA concentration for each genotype. Error bars show SDs; *n* = 3. Values significantly different from wild type at P \< 0.05 by Student's *t* test in K and L are indicated by asterisks.](JCB_201309141_Fig5){#fig5}

A previous study suggested that the transcriptional coactivator Mastermind (Mam), which normally contributes to Notch signaling, has an atypical role in FSCs, in which it collaborates closely with the Hh pathway ([@bib47]). We therefore tested whether *DIAP1-lacZ* expression was induced by excess Hh pathway activity in the absence of Mam function. We found that *DIAP1-lacZ* was not increased in *ptc mam* double mutant FSCs or FCs ([Fig. 5, E, J, and K](#fig5){ref-type="fig"}). We also found that *mam* mutant FSCs have reduced EdU incorporation (Fig. S5 B) and that the maintenance of *mam* mutant FSCs was rescued by expression of activated Yki ([Fig. 6, A and F](#fig6){ref-type="fig"}). Thus, Mam appears to be critical for excess Hh signaling to activate Yki in the FSC lineage, and *mam* mutant FSC loss may be caused by insufficient Yki activity.

![**Regulation of FSCs by Hh is mediated principally by induction of Yki.** (A--C) Percentage of ovarioles containing positively marked FSC clones 12 d after larval heat shock induction; dark red indicates all-marked clones. Each set of genotypes has the appropriate control (wild type \[WT\]) to the left. Horizontal black lines clarify correspondence between bars and genotypes. Blue brackets indicate critical comparisons. (B and C) All tests used a hypomorphic *smo* allele (*smo^7.6.6^*, right, angled stripes) and some (C) also used a strong, effectively null allele (*smo^2^*, left, solid shading). Error bars show SDs; *n* = 3, with ≥100 ovarioles scored in each measurement. Significant differences from wild type for all-marked FSC clones using Fisher's exact two-tailed test with P \< 0.05 are indicated by asterisks. (D--G) Ovarioles with clones induced 12 d earlier and marked by the presence of GFP, shown together with Fas3 and with FSCs indicated (arrowheads). All-marked FSC clones were induced by excess Yki (D) but not by *ptc* when *yki* is replaced by a *tub-yki* transgene (E). *mam* FSC clones were rescued by activated Yki (F), and *smo* FSC clones were rescued by excess CycE together with DIAP1 (G). Red bars, 10 µm.](JCB_201309141_Fig6){#fig6}

Hh induces *yki* transcription in the FSC lineage
-------------------------------------------------

Hh signaling normally influences cells by transcriptionally inducing cell type--specific target genes. We therefore tested whether Yki activation by Hh signaling in FSCs might be mediated by transcriptional induction of *yki* itself. Because reporters of Yki activity are activated by excess Hh pathway activity in both FSCs and FCs, we reasoned that the underlying mechanism was probably common to all cells of the FSC lineage and could be studied in samples containing both FSCs and FCs. We therefore isolated RNA from samples that included the germarium and all egg chambers of an ovariole up to stage 9. Analogous samples were collected from wild-type ovarioles and from ovarioles that were populated mostly by derivatives of either *ptc* or *hpo* mutant FSCs. We then measured the relative levels of key RNAs by quantitative RT-PCR, using *rp49* mRNA as an internal control. All three common Yki target genes tested (*DIAP1*, *cycE*, and *ex*) were induced in extracts from *hpo* mutant ovarioles and, to almost the same extent, in extracts from *ptc* mutant ovarioles ([Fig. 5 L](#fig5){ref-type="fig"}). Those observations confirmed our previous findings with *ex-lacZ* and *DIAP1-lacZ* reporter genes and also showed directly that both Hh and Hpo--Yki pathways induce *cycE* in the FSC lineage. Crucially, *yki* RNA was also induced in samples from *ptc* mutant FSC lineages ([Fig. 5 L](#fig5){ref-type="fig"}), showing that Hh signaling does indeed induce *yki* expression in the FSC lineage. In contrast, *yki* RNA was not induced in *hpo* mutant FSC lineages ([Fig. 5 L](#fig5){ref-type="fig"}), as expected because Hpo regulates Yki activity posttranscriptionally.

Hh regulates FSCs by inducing Yki transcriptionally and thereby stimulating FSC proliferation
---------------------------------------------------------------------------------------------

If Hh regulates FSCs by inducing *yki* transcription, excess Yki should mimic the effects of excess Hh signaling. Conversely, in the absence of Hh signaling, Yki protein levels may be too low to respond to inactivation of upstream Hpo pathway regulators. We found that excess wild-type Yki was indeed sufficient to produce increased FSC longevity and a significant frequency of all-marked clones ([Fig. 6, A and D](#fig6){ref-type="fig"}) as well as increased EdU incorporation (Fig. S5 B). The percentage of all-marked FSC clones was similar for FSCs with increased Hh pathway activity (*ptc* FSCs), increased Yki expression (from *UAS-yki*), or both alterations together (*ptc* + *UAS-yki*), consistent with the idea that Hh acts by increasing *yki* expression ([Fig. 6 A](#fig6){ref-type="fig"}). Likewise, the phenotype of *ptc hpo* double mutant FSCs was similar to the phenotype of *ptc* or *hpo* single mutant FSCs (Fig. S5 C). These results are consistent with the idea that maximal Hh signaling, inactivation of upstream Hpo pathway regulators of Yki, and excess Yki expression provide three routes to activate Yki, each of which produces a saturatingly high input from Yki into the proliferation rate and competitive behavior of FSCs.

Conversely, inactivation of the upstream Hpo pathway regulator Ex, which normally leads to posttranscriptional activation of Yki, enhanced FSC maintenance, and frequent all-marked FSC clones did not induce all-marked FSC clones in the absence of *smo* activity and did not even counter the rapid loss of *smo^7.6.6^* ([Fig. 6 B](#fig6){ref-type="fig"}) or *smo^2^* mutant FSCs (Fig. S5 F). Similarly, *smo hpo* and *smo wts* double mutant FSCs did not produce all-marked clones but instead exhibited accelerated FSC loss, similar to *smo* single mutant FSCs (Fig. S5 D). Thus, the requirement for Hh pathway input is downstream of, or parallel to, the input of conventional Hpo pathway regulators, consistent with our demonstration that Hh acts by inducing *yki* RNA, whereas upstream Hpo pathway components regulate the activity of Yki protein. It also appears that regulation of Yki activity by the Hpo pathway in FSCs is only effective when normal Hh signaling provides sufficient, but not excessive, *yki* transcription.

To test definitively whether *yki* induction by Hh is critical for FSC responses to Hh, we eliminated the transcriptional induction of *yki* by Hh signaling. To achieve this, we used a *tub-yki* transgene, in which the *yki* coding sequence is expressed from a heterologous, constitutive low-level promoter, to replace normal *yki* gene function. This transgene has previously been shown to rescue viability of *yki* mutant animals and must therefore be expressed at roughly physiological levels ([@bib13]). Indeed, *tub-yki* almost fully rescued *yki* mutant FSC clone maintenance ([Fig. 6 A](#fig6){ref-type="fig"}) and EdU incorporation (Fig. S5 B) and restored normal *DIAP1-lacZ* expression to *yki* mutant FCs (Fig. S4, C, D, and I). Also, *tub-yki* did not detectably increase *DIAP1-lacZ* expression in wild-type FCs (Fig. S4, A, B, and I), and unlike *UAS-yki* or *UAS-yki^S168^* expression, *tub-yki* did not cause any increase in proliferation of wild-type FSCs (Fig. S5 B). Hence, *tub-yki* must produce almost the same levels of Yki as in normal FSCs. When the constitutive *tub-yki* transgene was used to complement *yki* in FSCs, excess Hh signaling did not elevate *DIAP1-lacZ* reporter activity (in *ptc yki* FSC clones in animals with one copy of *tub-yki* in all cells, *ptc yki; tub-yki*; [Fig. 5, D, I, and K](#fig5){ref-type="fig"}). We therefore conclude that elevation of Yki activity by excess Hh pathway activity in otherwise normal FSCs is achieved by inducing *yki* expression.

Crucially, *ptc yki; tub-yki* FSCs, which have elevated Hh pathway activity but do not have elevated Yki activity, did not have an increased EdU incorporation frequency ([Fig. 4 A](#fig4){ref-type="fig"}) and did not produce all-marked clones ([Fig. 6, A and E](#fig6){ref-type="fig"}). Thus, all responses to excess Hh pathway activity seen in *ptc* mutant FSC clones (Yki activation, increased proliferation, and increased FSC competitiveness) were lost when normal regulation of Yki was substituted by constitutive Yki expression at a level appropriate for normal FSC function.

We also tested whether upstream Hpo pathway components can regulate Yki activity when normal transcriptional regulation of *yki* is prevented. We found that the phenotype of *hpo yki; tub-yki* FSCs was very similar to that of *hpo* mutant FSCs, producing many all-marked FSC clones (Fig. S5 C). Thus, upstream Hpo pathway components do not regulate Yki activity by modulating *yki* transcription, in accordance with precedent in other tissues and with our observation that *yki* RNA levels are unaltered in *hpo* mutant FSC clones ([Fig. 5 L](#fig5){ref-type="fig"}). Thus, substitution of *yki* with *tub-yki* clearly outlines the contrast between the effects of the Hh pathway on *yki* RNA levels and Hpo pathway components on Yki protein activity and defines Yki as the point of convergence of these two pathways in FSCs.

To investigate the importance of *yki* induction for FSC responses to normal levels of Hh signaling, we first tested whether excess Yki activity could restore deficits of *smo* mutant FSCs. We found that expression of activated Yki restored EdU incorporation in *smo* mutant FSCs and FCs to almost normal levels ([Fig. 4 A](#fig4){ref-type="fig"}) and substantially rescued *smo^7.6.6^* ([Fig. 6 B](#fig6){ref-type="fig"}) and *smo^2^* mutant FSC maintenance (Fig. S5 F). Thus, both the deficits in FSC proliferation and FSC maintenance as a result of loss of Hh pathway activity are substantially complemented by provision of excess Yki activity. We also found that *smo* mutant FSC maintenance was substantially rescued by the combined expression of excess CycE and DIAP1, two key targets of Yki in FSCs, but not by either alone ([Fig. 6, C and G](#fig6){ref-type="fig"}), just as observed for rescue of *yki* mutant FSCs ([Fig. 1 C](#fig1){ref-type="fig"}). Finally, we saw that *DIAP1-lacZ* activity in FCs was reduced in *smo* mutant FCs and restored by *tub-yki* (Fig. S4, G--I). *DIAP1-lacZ* expression in FSCs is too low to determine whether it can be reduced further by *yki* or *smo* mutations. These results support the idea that induction of Yki is an essential response to Hh signaling in normal FSCs.

However, some observations indicate that Yki induction is not the only way that Hh normally influences FSCs. Most convincing, excess wild-type or activated Yki induced many all-marked FSC clones, even in *yki* mutant FSCs but not in *smo* mutant FSCs (Fig. S5 E). Second, low levels of Yki, supplied by the *tub-yki* transgene, did not rescue *smo* FSC maintenance completely. In fact, rescue was slightly less effective than for *yki* mutant FSC maintenance ([Fig. 6, A and B](#fig6){ref-type="fig"}), even though Yki activity is compromised more by *yki* than by *smo* mutations (Fig. S4 I). Thus, activation of Yki and stimulation of cell cycling appear to be critical components of the response to normal Hh pathway activity in FSCs, whereas excessive induction of Yki and hyperproliferation are essential for the duplication and increased competitiveness of FSCs responding to excess Hh pathway activity.

Discussion
==========

Regulation of proliferation is clearly critical for all types of adult stem cells to ensure adequate, but not excessive, production of daughter cells for tissue maintenance. Our studies with FSCs have revealed a specific mechanism for regulating stem cell proliferation that centers on the Hpo--Yki pathway, a major conserved pathway that was initially recognized for its roles in regulating tissue size. Most importantly, the inductive connections among Hh, Yki, and CycE, coupled to their tightly correlated effects on FSC proliferation and maintenance, provide compelling evidence that the longevity and competitive strength of an FSC are regulated by controlling the rate of FSC proliferation.

Our results clearly show that an FSC lacking Yki or Hh pathway activity has reduced proliferation and is rapidly lost, whereas an FSC with excessive Yki or Hh pathway activity has an increased proliferation rate, extended longevity, and frequently duplicates and outcompetes wild-type FSCs in the same germarium. It is also clear that excess Hh pathway activity increases Yki activity in FSCs and that the increased proliferation, longevity, and competitive strength of such FSCs is completely suppressed when the endogenous *yki* gene is inactivated in animals that have a *tub-yki* transgene. We argue that the latter observation shows that all responses to excess Hh pathway activity depend on inducing Yki activity.

We measured a three- to fourfold increase in FSC Yki activity using a *DIAP1-lacZ* reporter and an induction of less than twofold for both *yki* and *diap1* RNA in quantitative RT-PCR measurements using ovarioles with *ptc* mutant FSC clones. The latter experiment almost certainly underestimates induction in FSCs because the samples included some wild-type FSC lineages and many *ptc* mutant FCs, which show less induction of Yki activity than FSCs ([Fig. 5 K](#fig5){ref-type="fig"}). We therefore surmise that a three- to fourfold increase in Yki activity gives an FSC a large competitive advantage.

FSCs expressing *UAS-Yki* and *UAS-Yki^S168A^* presumably also reached this threshold of excessive Yki activity because they induced many all-marked FSC clones and increased EdU incorporation in FSCs. In contrast, the *tub-yki* transgene likely produces Yki levels similar to those in wild-type FSCs because *DIAP1-lacZ* activity and EdU incorporation in *yki* mutant FSCs expressing *tub-yki* were not significantly higher or lower than in wild-type FSCs (Fig. S4 and Fig. S5). Hence, complementation of *yki* loss of function with *tub-yki* provided a suitable, normal level of *yki* expression to test the effects of elevating Hh pathway activity. In those tests, there was no measurable response at all to loss of *ptc*, even though *ptc* mutations in a wild-type background strongly increase the expression of reporters of Yki activity (*DIAP1-lacZ* and *ex-lacZ*) and produce very strong phenotypes of increased FSC proliferation, FSC longevity, and FSC duplication. Hence, we have no reservations in concluding that excess Hh pathway activity makes an FSC more competitive by increasing *yki* transcription and hence Yki activity.

The next critical question is whether increased Yki activity makes an FSC more competitive by increasing its proliferation rate. We showed that the competitive advantage of FSCs with increased Yki activity (in *ex* mutant FSC clones) was lost when induction of CycE activity was lost (*cycE^AR95^)* or greatly reduced (*cycE^WX^*) by complementing *cycE* mutations with a *UAS-cycE* transgene. The same *UAS-cycE* transgene almost fully complemented the FSC maintenance defects of both *cycE* alleles without inducing all-marked FSC clones in these or otherwise normal FSCs, as shown previously ([@bib49]) and repeated here. We therefore conclude that CycE activity provided by the *UAS-cycE* transgene is likely slightly lower than in wild-type FSCs. Hence, CycE activity induced by excess Yki activity acting on a normal *cycE* gene must be much higher than the activity provided by *UAS-cycE*. The failure of Yki activation to induce all-marked FSCs, or indeed to alter the longevity of *cycE; UAS-cycE* FSCs at all, can therefore be attributed, logically and reasonably, to a failure to induce *cycE* transcriptionally. We conclude that increased CycE activity is critical for increased Yki activity, and therefore, by inference, for excess Hh pathway activity, to make an FSC more competitive. Whether increased DIAP1 activity is also critical was not tested.

The substantial rescue of *smo* FSC maintenance and *smo* FSC EdU incorporation by a *tub-yki* transgene that approximates normal levels of *yki* expression in FSCs ([Fig. 4 A](#fig4){ref-type="fig"} and [Fig. 6 B](#fig6){ref-type="fig"}) suggests that *yki* induction by Hh signaling is also important for the proliferation and maintenance of normal FSCs. The logical extrapolation that *cycE* induction (via Yki) is also a critical consequence of normal Hh signaling is further supported by the finding that *smo* mutant FSC clones are substantially rescued by coexpression of DIAP1 and a CycE transgene at a level that produces approximately normal levels of CycE activity ([Fig. 6 C](#fig6){ref-type="fig"}). As discussed earlier, Yki does not appear to be the only significant target for normal Hh signaling in FSCs because excessive Yki activity supplied by a transgene (*UAS-yki* or *UAS-yki^S168A^*) provides a greater competitive advantage for *yki* mutant FSCs than for *smo* mutant FSCs (Fig. S5 E).

We have not determined whether the Hh pathway transcriptional effector Cubitus interruptus (Ci) induces Yki directly or indirectly in FSCs. However, *yki* is induced transcriptionally in response to Hh signaling on the basis of direct RNA measurements and suppression of Yki activity induction by excess Hh pathway activity in *yki; tub-yki* FSCs. Similarly, we do not know whether the transcriptional coactivator Mam acts directly at the *yki* locus or whether it interacts physically with Ci. However, the observation that Mam is required for excess Hh signaling to induce Yki activity in FSCs ([Fig. 5, E, J, and K](#fig5){ref-type="fig"}) suggests that Mam is required for transcriptional induction of *yki*. Mam is not required for induction of known Hh target genes in wing discs ([@bib47]), and Hh does not induce Yki activity in wing discs (Fig. S3, H--M), suggesting that the role of Mam in FSCs is tissue specific. The role of Mam in FSCs has previously been shown to be independent of Notch signaling ([@bib47]), and hence, the simplest hypothesis is that Mam collaborates directly with Ci specifically in the FSC lineage to induce *yki*.

The Hpo pathway has attracted great interest as a conserved regulator of cell proliferation that can influence tissue size, prompting investigation of whether it sometimes acts at the level of stem cells ([@bib36]). In both fly and mammalian gut stem cells Yki, or its orthologue Yes-associated protein (YAP), is required in the stem cell for damage-induced proliferation but not for normal stem cell maintenance ([@bib3]; [@bib17]; [@bib38]; [@bib41]). Under stress conditions, the Hpo pathway also regulates gut stem cell proliferation indirectly by altering the differentiation or behavior of critical niche cells and hence the production of ligands for multiple other influential signaling pathways, including Wnt, JAK-STAT, and Notch ([@bib14]; [@bib1]; [@bib22]). Yki/YAP proteins are also apparently dispensable for mammalian HSC ([@bib15]) and *Drosophila* GSC maintenance (this study) under normal physiological conditions. The niche-regulated, direct, and constitutive proliferative role we uncovered for Yki in FSCs may, however, be mirrored in mammalian epidermal stem cells, in which YAP directly supports normal stem cell proliferation and induces dramatic hyperplasia when released from restraint by upstream components that include α-catenin ([@bib40]).

Importantly, FSCs have provided an opportunity to understand how an essential proliferative action of the Hpo pathway is integrated into the normal physiological regulation of a stem cell population, revealing two key relationships. First, for FSCs, we find that regulated stem cell proliferation and stem cell maintenance are causally and positively linked. That relationship was originally considered unlikely for any stem cell based on considerations of the potential for replicative DNA damage and evidence of HSC loss in response to enforced proliferation. However, even for HSCs, the direct impact of regulated proliferation has been difficult to assess definitively because a few genetic manipulations that increase HSC division rates (such as loss of Cdkn2c/p18 or c-Myb) do not impair HSC maintenance, whereas the few direct manipulations of niche factor signaling responses that affect both stem cell proliferation and maintenance do not prove a causal connection between these two responses ([@bib32]; [@bib34]; [@bib53]; [@bib39]). In contrast, it is likely that maintenance of highly proliferative stem cells is, at worst, indifferent to high rates of stem cell division. Indeed, Wnt signaling can promote proliferation of mammalian intestinal stem cells, and loss of Wnt signaling pathway components or a key transcriptional target, c-Myc, implicated in growth control was shown to result in stem cell loss, suggesting that proliferation likely stimulates intestinal stem cell maintenance ([@bib6]). However, even in this well-studied paradigm, it remains possible that responses to Wnt or c-Myc other than changes in stem cell proliferation rate play an important role in regulating stem cell maintenance ([@bib12]; [@bib6]). A key strength of our experiments was the demonstration that it is specifically the proliferative response to Hh signaling, which acts directly in a cell-autonomous manner to regulate the maintenance and competitive behavior of a stem cell. It will be very important to establish rigorously whether regulated stem cell proliferation and maintenance are indeed causally linked in some mammalian stem cells, as in FSCs, because this has important consequences for cancer biology. As illustrated by *ptc* or *hpo* mutations in FSCs, activation of either regulatory pathway in a single stem cell would, in one step, induce expansion and increased longevity of the activated stem cell and confer inherited hyperproliferation on daughter cells.

Second, we discovered how stem cells can be regulated by tissue-specific coupling of two widely used and conserved signaling pathways, Hh and Hpo. Normal FSC behavior was previously shown to require a precise level of Hh pathway activity ([@bib48]), which we now find is translated into Yki and CycE activities sufficient to stimulate appropriate, but not excessive, FSC proliferation. This is achieved by linking Hh and Hpo pathways through transcriptional induction of *yki*, involving a noncanonical role of the Notch coactivator Mam. This mode of coupling is inherently versatile because the transcriptional targets of Hh and other signaling pathways vary extensively according to cell type; indeed, the robust coupling we observed in the FSC lineage was not evident in wing disc cells. An analogous tissue-specific linkage in mammals would provide a mechanism for selectively regulating a specific stem cell or progenitor cell type, with the accompanying susceptibility to cancer-initiating mutations. In fact, it has already been found that Sonic Hh stimulates both transcription of the Yki orthologue YAP1 and proliferation in human cerebellar granule neural precursors and that elevated YAP1 activity contributes to the cancerous phenotype of some murine medulloblastomas induced by excess Hh pathway activity ([@bib8]). It remains to be established whether YAP1 is involved in the regulation of other Hh-responsive stem cells or Hh-initiated tumors in mammals.

Materials and methods
=====================

*Drosophila* stocks and clonal analysis
---------------------------------------

For clonal analyses, we used *FRT19A* (control), *scalloped^\[47M\]^ FRT19A*, *mer^3^ FRT19A*, *mer^4^ FRT19A*, *NM FRT40A* (control), *ex^NY1^ FRT40A*, *ex^e1^ FRT40A*, *ed^IF20^ FRT40A*, *ed^F72^ FRT40A*, *fat^8^ FRT40A*, *d^G13^ FRT40A*, *FRT42D sha* (control), *FRT42D yki^B5^*, *FRT42D hpo^42-47^*, *FRT42D hpo^KC202^*, *FRT42D hpo^42-47^yki^B5^*, *FRT42D ptc^S2^*, *FRT82B NM* (control), *FRT82B dRassf^X36^*, *FRT82B crb^11A22^*, *FRT82B crb^82-04^*, *FRT82B sav^3^*, *FRT82B wts^×1^*, *FRT82B kibra^Δ32^*, and *FRT82Bkibra^del^*. These flies were crossed to *hs-Flp; ubi-mRFP.nls FRT19A*, *hs-Flp; ubi-GFP.nls FRT40A*, *hs-Flp; FRT42D ubi-GFP.nls*, or *hs-Flp; FRT82B ubi-GFP.nls* flies for negatively marked clones. For positively marked clones, we either used alleles on an *FRT40A* chromosome (*NM*, *smo^2^*, *smo^7.6.6^*, *ex^NY^*^1^, *cycE^AR95^*, *cycE^WX^*, *ex^NY1^cycE^AR95^*, *ex^NY1^cycE^WX^*, *ex^NY1^smo^2^*, or *ex^NY1^smo^7.6.6^*) crossed to *hs-Flp, UAS-GFP, tub-GAL4; tub-GAL80 FRT40A/Cyo; act\>CD2\>Gal4* or alleles on an *FRT42D* chromosome (*sha*, *yki^B5^*, *hpo^42-47^*, *ptc^S2^*, *ptc^S2^yki^B5^*, *mam^8^*, or *ptc^S2^mam^8^*) crossed to *hs-Flp, UAS-GFP, tub-GAL4; FRT42D tub-GAL80/Cyo; act\>CD2\>Gal4*. *UAS-cycE*, *UAS-DIAP1*, *UAS-DIAP1* + *UAS-cycE*, *UAS-yki^S168A^*, *UAS-yki^WT^*, *tub-yki^WT^*, *UAS-yki RNAi*, *UAS-fj RNAi*, and *UAS-zyx RNAi* were added to the third chromosomes of these crosses when needed. Third chromosome Hpo pathway reporters *DIAP1-lacZ* and *ex-lacZ* were added to stocks for negative clone marking. To induce *smo hpo* double mutant clones, we used flies of the genotype *yw hs-Flp; smo^3^ FRT42D hpo^42-47^/smo^3^ FRT42D P\[smo^+^\] ubi-GFP.nls* and *yw hs-Flp; FRT42D hpo^42-47^* (*or hpo^+^*)*/smo^3^ FRT42D P\[smo^+^\] ubi-GFP.nls* to generate *hpo* mutant and control clones in a *smo/+* background. To induce *smo wts* double mutant clones, we used flies of the genotype *yw hs-Flp; smo^2^ FRT40A/ubi-GFP FRT40A; FRT82B wts^×1^/FRT82B H2Av-RFP* with controls lacking the *smo* mutation. Larvae or adult flies of the appropriate genotype were heat shocked for 1 h at 37°C to induce negatively or positively marked clones. For positive marking, flies were incubated at 29°C for ≥2 d before dissection to increase the expression of GFP. *Drosophila* stocks were obtained from the Bloomington Stock Center and from D. Pan (Johns Hopkins Medical School, Baltimore, MD; *kibra^del^* \[[@bib54]\], *scalloped^\[47M\]^* \[[@bib51]\], *crb^82-04^* \[[@bib23]\], *yki^B5^*, and *hpo^42-47^* \[[@bib13]\]), N. Tapon (London Research Institute, London, England, UK; *kibra^Δ32^* \[[@bib10]\], *dRassf^X36^* \[[@bib35]\], and *sav^3^* \[[@bib45]\]), N. Perrimon (Harvard Medical School, Boston, MA; *UAS-yki*, *DIAP1-lacZ*, and *ex-lacZ*; [@bib17]), L. Johnston (Columbia University Medical School, New York, NY; *tub-yki* \[*yki^αTub84B.PD^* in FlyBase\]; [@bib29]), K. Irvine (Columbia University Medical School, New York, NY; *UAS-zyx RNAi* \[*zyx^dsRNA.Scer\\UAS^* in FlyBase\]; [@bib37]), N. Baker (Albert Einstein College of Medicine, New York, NY; *ex^NY12^*; [@bib46]), K. Basler (University of Zurich, Zurich, Switzerland; *P\[smo^+^\]* \[*smo^+tMa^* in FlyBase\]; [@bib28]), J.-C. Hsu (National Tsing Hua University, Hsinchu, Taiwan; *ed^IF20^*; [@bib7]), and L. Nilson (McGill University, Montreal, Quebec, Canada; *ed^F72^*; [@bib20]). All alleles and transgenes are described in FlyBase except for *smo^7.6.6^*, which carries an unknown ethyl methanesulfonate--induced mutation and is described in [@bib50]. Specific Bloomington Stock Center lines used for dsRNA transgenes were *UAS-yki RNAi* (BL\#31965) and *UAS-fj RNAi* (BL\#28009).

Immunohistochemistry and microscopy
-----------------------------------

Ovaries were dissected in PBS and fixed in 4% paraformaldehyde in PBS for 20 min, rinsed twice with PBST (PBS containing 0.1% Triton X-100 and 0.05% Tween 20), blocked with 5% normal goat serum (Jackson ImmunoResearch Laboratories, Inc.) in PBST for 1 h, and stained with the following primary antibodies: mouse anti-Fas3 (1:250; Developmental Studies Hybridoma Bank), rabbit anti--β-galactosidase (1:500; Promega), and rabbit anti-GFP (1:1,000; Molecular Probes) overnight at 4°C. Ovaries were then washed three times in PBST for 20 min each and incubated with Alexa Fluor 488, Alexa Fluor 595, or Alexa Fluor 647 secondary antibodies (1:1,000; Molecular Probes) for 2 h at room temperature. Ovaries were washed twice in PBST for 20 min each and once in PBS for 10 min and mounted in Aqua-Poly/Mount (Polysciences, Inc.). Fluorescence images were captured at room temperature (∼22°C) using 40×, 1.3 NA or 63×, 1.4 NA oil immersion lenses on a confocal microscope (LSM 700; Carl Zeiss). Images were processed using ImageJ (National Institutes of Health) and Photoshop (Adobe). For measurement of *DIAP1-lacZ* and *ex-lacZ* staining, ImageJ software was used to find a mean intensity from three areas within each cell, sampling ≥18 FSCs and ≥300 FCs in each case, to produce a single mean intensity value. These measurements were repeated three times to avoid sampling area bias, and SDs were calculated from the three sets of mean intensity values obtained.

EdU labeling
------------

EdU labeling was performed using the EdU imaging kit (Click-iT; Invitrogen). Ovaries dissected in PBS were rinsed twice in 3% BSA in PBS, incubated in 15 µM EdU solution in PBS for 1 h, rinsed twice with 3% BSA, and fixed in 4% paraformaldehyde for 10 min. Ovaries were washed 10 min with 3% BSA and 20 min with PBST and then stained with the primary antibody for 1 h at room temperature. After washing once in PBST for 20 min and twice in 3% BSA for 10 min each, ovaries were incubated in Click-iT reaction cocktail for 30 min at room temperature. Ovaries were rinsed once in 3% BSA and washed twice in PBST for 10 min each and then incubated with secondary antibodies for 2 h at room temperature. Ovaries were washed twice in PBST for 20 min each followed by PBS for 10 min and mounted.

Quantitative RT-PCR
-------------------

*FRT42D sha* (control), *FRT42D ptc^S2^*, and *FRT42D hpo^42-47^* flies were crossed with *hs-Flp; FRT42D ubi-GFP.nls* flies to induce negatively marked clones in ovaries. The larvae of the appropriate genotype were heat shocked for 1 h at 37°C and then dissected 12 d after heat shock. The germarium and early egg chambers (up to stage 9) were collected using the hyperplastic *ptc* and *hpo* phenotypes to identify ovarioles harboring those mutant FSC clones. RNA was isolated using the RNeasy Mini kit (QIAGEN) according to the manufacturer's protocol. Quantitative RT-PCR was performed in the StepOnePlus Real-Time PCR System with Power SYBR Green RNA-to-C~T~ 1-Step Kit (Applied Biosystems). Primers for amplifying 100--200 bp of each PCR product are listed in [Table S2](http://www.jcb.org/cgi/content/full/jcb.201309141/DC1){#supp9}. RT-PCR reactions were performed for 30 min at 48°C followed by 10 min at 95°C and then followed by 40 cycles of two-step PCR for 15 s at 95°C and 1 min at 60°C. Each sample was performed in triplicate. The mRNA levels of target genes (*DIAP1*, *cycE*, *ex*, *yki*, and *ptc*) were normalized to *rp49* mRNAs, and the relative quantification in gene expression between mutants and control was determined using the 2^−ΔΔCt^ method ([@bib24]).

Online supplemental material
----------------------------

Fig. S1 shows that *yki* mutant FSCs are lost very rapidly and that *yki* mutant FCs have increased apoptosis. Fig. S2 shows that core components of the Hpo pathway regulate FSCs, whereas several known upstream regulators do not. Fig. S3 shows that excess Hh activity induces Yki activity, measured with an *ex-lacZ* reporter, cell autonomously in FSCs but not in wing disc cells. Fig. S4 shows that a *tub-yki* transgene rescues Yki activity in *yki*, *ptc yki*, and *smo* mutant FCs but does not confer excessive Yki activity on wild-type cells. Fig. S5 shows that EdU incorporation is no longer enhanced by excess Yki activity in FSCs when *cycE* is not inducible, that Yki transgenes complement proliferation defects and FSC maintenance defects in *yki*, *smo*, and *mam* mutant FSCs to different degrees, that the *hpo* mutant phenotype is not altered by additional loss of *ptc* or substitution of *yki* with a constitutive *yki* transgene, and that *smo* mutant FSC maintenance is restored by a hyperactive Yki transgene but not by activation of Yki in response to loss of the upstream regulators Hpo, Wts, or Ex. Table S1 shows fractions of GFP-labeled cells of the indicated genotypes and cell types with EdU labeling. Table S2 shows primers used for quantitative real-time PCR. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201309141/DC1>.

Supplementary Material
======================

###### Supplemental Material

We thank Ken Irvine, Laura Johnston, Nicolas Tapon, Duojia Pan, Norbert Perrimon, Nicholas Baker, Jui-Chou Hsu, Laura Nilson, and the Bloomington Stock Center for providing critical *Drosophila* stocks. We also thank Amy Reilein, Elisa Garcia, and Jamie Little for advice and discussion.

This work was supported by National Institutes of Health grant GM079351 to D. Kalderon and benefited from core imaging facilities provided by the Department of Biological Sciences.

The authors declare no competing financial interests.

Abbreviations used in this paper:*actactin*APanterior--posteriorBMPbone morphogenetic proteinCiCubitus interruptusCycECyclin EDppDecapentaplegicECescort cellEdU5-ethynyl-2′-deoxyuridineExExpandedFas3Fasciclin3FCfollicle cellFSCfollicle stem cellGSCgermline stem cellHhHedgehogHpoHippoHSChematopoietic stem cellJAK-STATJanus kinase--signal transducer and activator of transcriptionMamMastermindMARCMmosaic analysis with a repressible cell markerMerMerlin*ptcpatched*SavSalvador*smosmoothenedtubtubulinubiubiquitin*WtsWartsYAPYes-associated proteinYkiYorkie
